Literature DB >> 31665382

Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients.

German Rubinstein1, Andrea Osswald1, Eva Hoster2, Marco Losa3, Atanaska Elenkova4, Sabina Zacharieva4, Márcio Carlos Machado5, Felicia Alexandra Hanzu6, Stephanie Zopp1, Katrin Ritzel1, Anna Riester1, Leah Theresa Braun1, Ilonka Kreitschmann-Andermahr7, Helen L Storr8, Prachi Bansal9, María-José Barahona10, Elisa Cosaro11, Sema Ciftci Dogansen12, Philip C Johnston13, Ricardo Santos de Oliveira14, Christian Raftopoulos15, Carla Scaroni16, Elena Valassi17, Steven J A van der Werff18, Jochen Schopohl1, Felix Beuschlein1,19, Martin Reincke1.   

Abstract

CONTEXT: Signs and symptoms of Cushing's syndrome (CS) overlap with common diseases, such as the metabolic syndrome, obesity, osteoporosis, and depression. Therefore, it can take years to finally diagnose CS, although early diagnosis is important for prevention of complications.
OBJECTIVE: The aim of this study was to assess the time span between first symptoms and diagnosis of CS in different populations to identify factors associated with an early diagnosis. DATA SOURCES: A systematic literature search via PubMed was performed to identify studies reporting on time to diagnosis in CS. In addition, unpublished data from patients of our tertiary care center and 4 other centers were included. STUDY SELECTION: Clinical studies reporting on the time to diagnosis of CS were eligible. Corresponding authors were contacted to obtain additional information relevant to the research question. DATA EXTRACTION: Data were extracted from the text of the retrieved articles and from additional information provided by authors contacted successfully. From initially 3326 screened studies 44 were included. DATA SYNTHESIS: Mean time to diagnosis for patients with CS was 34 months (ectopic CS: 14 months; adrenal CS: 30 months; and pituitary CS: 38 months; P < .001). No difference was found for gender, age (<18 and ≥18 years), and year of diagnosis (before and after 2000). Patients with pituitary CS had a longer time to diagnosis in Germany than elsewhere.
CONCLUSIONS: Time to diagnosis differs for subtypes of CS but not for gender and age. Time to diagnosis remains to be long and requires to be improved. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ACTH; cortisol; hypercortisolism; meta-analysis; symptoms

Mesh:

Year:  2020        PMID: 31665382     DOI: 10.1210/clinem/dgz136

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort.

Authors:  Sanna Toivanen; Helena Leijon; Aura Arola; Minna Soinio; Päivi O Hämäläinen; Saara Metso; Otto Knutar; Minna Koivikko; Tapani Ebeling; Leena Moilanen; Leena Norvio; Marjo Tamminen; Päivi Rautiainen; Satu Vehkavaara; Eeva Ryhänen; Tuula Pekkarinen; Niina Matikainen; Timo Sane; Camilla Schalin-Jäntti
Journal:  Endocrine       Date:  2021-05-25       Impact factor: 3.633

2.  [36/f-Facial swelling and flushing, back pain and leukocytosis : Preparation for the medical specialist examination: part 143].

Authors:  U D Lichtenauer
Journal:  Internist (Berl)       Date:  2022-04-04       Impact factor: 0.743

Review 3.  Consensus on diagnosis and management of Cushing's disease: a guideline update.

Authors:  Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-20       Impact factor: 32.069

4.  Pituitary tumor centers of excellence for Cushing's disease.

Authors:  Marcos Couselo; Stefano Frara; Andrea Giustina; Felipe F Casanueva
Journal:  Pituitary       Date:  2022-09-10       Impact factor: 3.599

5.  Unmet needs in Cushing's syndrome: the patients' perspective.

Authors:  Elena Valassi; Iacopo Chiodini; Richard A Feelders; Cornelie D Andela; Margueritta Abou-Hanna; Sarah Idres; Antoine Tabarin
Journal:  Endocr Connect       Date:  2022-06-24       Impact factor: 3.221

Review 6.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

7.  Bedtime Salivary Cortisol as a Screening Test for Cushing Syndrome in Children.

Authors:  Grethe Å Ueland; Ralf Kellmann; Melissa Jørstad Davidsen; Kristin Viste; Eystein S Husebye; Bjørg Almås; Helen L Storr; Jørn V Sagen; Gunnar Mellgren; Petur B Júlíusson; Paal Methlie
Journal:  J Endocr Soc       Date:  2021-03-04

Review 8.  Toward a Diagnostic Score in Cushing's Syndrome.

Authors:  Leah T Braun; Anna Riester; Andrea Oßwald-Kopp; Julia Fazel; German Rubinstein; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

9.  Circulating microRNA Expression in Cushing's Syndrome.

Authors:  Sharmilee Vetrivel; Ru Zhang; Mareen Engel; Barbara Altieri; Leah Braun; Andrea Osswald; Martin Bidlingmaier; Martin Fassnacht; Felix Beuschlein; Martin Reincke; Alon Chen; Silviu Sbiera; Anna Riester
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-22       Impact factor: 5.555

10.  Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.

Authors:  Daniel Bengtsson; Oskar Ragnarsson; Katarina Berinder; Per Dahlqvist; Britt Edén Engström; Bertil Ekman; Charlotte Höybye; Pia Burman; Jeanette Wahlberg
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.